Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCL10 is an inflammatory chemokine secreted by various cell types in response to interferon-gamma (IFN-γ). It plays a crucial role in recruiting and activating immune cells, particularly T cells, to sites of inflammation or infection. Its primary receptor is CXCR3, and its signaling leads to a variety of cellular responses, including cell migration, apoptosis, and angiogenesis inhibition. CXCL10 is implicated in numerous diseases, including viral infections, autoimmune disorders, and cancer, making it a potential therapeutic target.
Binding to CXCR3 activates G-protein-mediated signaling pathways, leading to downstream effects like phospholipase C activation, increased intracellular calcium, actin cytoskeleton reorganization, and cell migration/activation/differentiation/apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine (C-X-C motif) ligand 10 (CXCL10).